Recent Finacing
Recent Raise
Apitope uses a proprietary platform to develop disease‑modifying therapies for autoimmune and allergic diseases, advancing candidates for multiple sclerosis, Graves' disease, haemophilia A inhibitor tolerance, and uveitis.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
